Clinical Trials Browser

Enrolling by invitation × Bevacizumab × Gastrointestinal × Clear all

NCT05441475 2026-02-25

A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients

Phase 2 Enrolling by invitation

Gastrointestinal

Carcinoma, Hepatocellular

NCT06849362 2025-02-27

Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer

Enrolling by invitation

Gastrointestinal

Colorectal Neoplasms